thelancetendo.bsky.social
Your leading source of international, cutting-edge research, review, and opinion in clinical #diabetes and #endocrinology. IF=36·3. 🌐 thelancet.com/journals/landia/home
👤 Joined on 03 February 2025
Followers
Following
Total Posts
@thelancetendo.bsky.social🔬 Don’t miss this important session! Join Prof. Chantal Mathieu for a Lab Talk at #EASD2026. 📅 2 Oct |🕙10:15 - 10:45 CEST | 📍 Arena Hear about her #lab, her #research & how she leads her team. Make sure to join the conversation in the Arena! It's going to be a great one! #Diabetes #LabTalk
Show Post🔴 Happening now at #EASD2026. Today's session draws on insights from a major Phase 3 efficacy trial: TRIUMPH-2 of retatrutide in people with obesity & T2D with: 🎤 John Wilding 🎤 Juan Pablo Frias 🎤 Elif Ekinci 🎤 Elisabeth Van Rossum Chaired by Arya M. Sharma 📍 Happening now in the Paris Hall
Show PostEarly detection saves lives. EU Commissioner Olivér Várhelyi launched the “#KnowYourNumbers” campaign for the first-ever #EUScreeningWeek. @easdnews.bsky.social, @escardio.bsky.social,@easoobesity.bsky.social &@eudiabetesforum.bsky.social welcome the proposal. 👉 health.ec.europa.eu/know-your-nu...
Show PostA new framework published today in @thelancetendo.bsky.social sets out 35 core outcomes for testing interventions to modify the progression of #type2diabetes. Researchers from @arc-em.bsky.social and @uniofleicester.bsky.social are part of the team behind it. 🔗 arc-em.nihr.ac.uk/news/type-2-...
Show PostAlmost all u need 2 know about the remarkable clinical effects of #SGLT2i on the kidney in a wide ranging IPD metaanalysis (covers effects by albuminuria, predicted eGFR dip and novel exploratory eGFR slope methods). Please do read it! @oxpop.bsky.social @martinlandray.bsky.social
Show Post